US 11124567
Anti-TREM2 antibodies and methods of use thereof
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 11124567 (Anti-TREM2 antibodies and methods of use thereof) held by DENALI THERAPEUTICS INC. expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DENALI THERAPEUTICS INC.
- Grant date
- Tue Sep 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K2039/505, A61K2039/545